New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 200mg;   - capsule - 200 mg - active: pregabalin 200mg   excipient: colloidal silicon dioxide   gelatin   iron oxide red   lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 225mg;   - capsule - 225 mg - active: pregabalin 225mg   excipient: colloidal silicon dioxide   gelatin   iron oxide red lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 25mg;   - capsule - 25 mg - active: pregabalin 25mg   excipient: colloidal silicon dioxide   gelatin   lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 300mg;   - capsule - 300 mg - active: pregabalin 300mg   excipient: colloidal silicon dioxide   gelatin   iron oxide red lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 50mg;   - capsule - 50 mg - active: pregabalin 50mg   excipient: colloidal silicon dioxide   gelatin   lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 75mg;   - capsule - 75 mg - active: pregabalin 75mg   excipient: colloidal silicon dioxide   gelatin   iron oxide red lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ondansetron hydrochloride dihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - ondansetron hydrochloride dihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - midazolam, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium chloride; sodium hydroxide - intravenously as an agent for: conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures such as bronchoscopy, gastroscopy, cystoscopy,coronary angiography and cardiac catheterisation, either alone or in conjunction with an opioid. induction of anaesthesia preliminary to administration of other anaesthetic agents. with the use of an opioid premedicant, induction of anaesthesia can be obtained with a narrower dose range and in a shorter period of time. intermittent intravenous administration or continuous infusion for: sedation in intensive care units. intramuscularly for: preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - cytarabine, quantity: 500 mg - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; sodium chloride - indications as at 24 october 2001: cytarabine is indicated primarily for: induction and maintenance of remission in acute myelocytic leukaemia of both adults and children. it has also been found to be useful in the treatment of other leukaemias such as acute lymphocytic leukaemia, chronic myelocytic leukaemia (blast phase). cytarabine may be used alone or in combination with other antineoplastic agents, the best results are often obtained with combined therapy. children with non-hodgkin's lymphoma have benefited from a combination drug program (lsa212) that includes cytarabine. remissions induced by cytarabine not followed by maintenance treatment have been brief. maintenance therapy has extended these and provided useful and comfortable remissions with relatively little toxicity. cytarabine has been used intrathecally in meningeal leukaemia. focal leukaemic involvement of the central nervous system may not respond to intrathecal cytarabine and may better be treated with radiotherapy.